ClinVar Miner

Submissions for variant NM_019892.6(INPP5E):c.1402C>T (p.Arg468Cys)

gnomAD frequency: 0.00002  dbSNP: rs375909217
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Blueprint Genetics RCV001074129 SCV001239698 uncertain significance Retinal dystrophy 2019-01-16 criteria provided, single submitter clinical testing
Centre for Mendelian Genomics, University Medical Centre Ljubljana RCV001198896 SCV001369891 uncertain significance Joubert syndrome 1 2020-04-01 criteria provided, single submitter clinical testing This variant was classified as: Uncertain significance. The available evidence on this variant's pathogenicity is insufficient or conflicting. The following ACMG criteria were applied in classifying this variant: PM2,PP3.
Invitae RCV001320437 SCV001511221 likely pathogenic Familial aplasia of the vermis 2023-11-27 criteria provided, single submitter clinical testing This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 468 of the INPP5E protein (p.Arg468Cys). This variant is present in population databases (rs375909217, gnomAD 0.006%). This missense change has been observed in individuals with INPP5E-related conditions (PMID: 34188062; Invitae). ClinVar contains an entry for this variant (Variation ID: 866269). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt INPP5E protein function with a positive predictive value of 95%. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.
Ocular Genomics Institute, Massachusetts Eye and Ear RCV001376361 SCV001573478 uncertain significance Rod-cone dystrophy 2021-04-08 criteria provided, single submitter research The INPP5E c.1402C>T variant was identified in an individual with retinitis pigmentosa with a presumed recessive inheritance pattern. Through a review of available evidence we were able to apply the following criteria: PM2. Based on this evidence we have classified this variant as Variant of Uncertain Significance.
GeneDx RCV003329377 SCV004036945 likely pathogenic not provided 2023-09-23 criteria provided, single submitter clinical testing Observed with a likely pathogenic variant in siblings with juvenile-onset rod cone degeneration in published literature, but it is not known whether the variants occurred on the same (in cis) or on different (in trans) chromosomes (Sangermano et al., 2021); Not observed at a significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 23386033, 34188062)
PreventionGenetics, part of Exact Sciences RCV004528376 SCV004108571 uncertain significance INPP5E-related disorder 2024-01-23 criteria provided, single submitter clinical testing The INPP5E c.1402C>T variant is predicted to result in the amino acid substitution p.Arg468Cys. This variant was reported in an individual with retinal degeneration (Sangermano et al. 2021. PubMed ID: 34188062, supplementary data). This variant is reported in 0.0058% of alleles in individuals of Latino descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.